AIM
RMD icon

Advyzon Investment Management’s ResMed RMD Stock Holding History

Advyzon Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-815
Closed -$223K – 598
2025
Q3 		$223K Buy
815
+29
+4% +$7.92K 0.04% 408
2025
Q2 		$203K Buy
+786
New +$187K 0.04% 368

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Advyzon Investment Management's RMD Position: Q4 2025 in Review

Advyzon Investment Management sold out of ResMed (RMD) in Q4 2025, closing a stake of 815 shares — an estimated $223K sold.

Advyzon Investment Management first reported a position in RMD in Q2 2025 and held it in 2 quarters. The position peaked at $223K in Q3 2025. 948 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Advyzon Investment Management reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Advyzon Investment Management sold 815 ResMed shares in Q4 2025, an estimated $223K.
  • Advyzon Investment Management first reported a position in ResMed in Q2 2025 and held it in 2 quarters.
  • Advyzon Investment Management's ResMed position peaked at $223K in Q3 2025.
  • 948 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Advyzon Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.